Filovirus

Bivalent Thermostabilized Filovirus Vaccine Demonstrated 100% Success Rate Against Lethal Marburg Virus After Showing Full Protection Against Ebola

Medicine & Technology Jun 23, 2022

Soligenix Inc. (SNGX) recently announced that its bivalent, thermostabilized vaccine provides protection to non-human primates against Marburg virus disease after showing the same success against Ebola virus. Read the article for further details.

Ebola may have existed over 20 million years ago, according to researchers

Oct 28, 2014

Researchers from the University of Buffalo traces Ebola's roots to as far as 20 millions years ago

Filovirus

Bivalent Thermostabilized Filovirus Vaccine Demonstrated 100% Success Rate Against Lethal Marburg Virus After Showing Full Protection Against Ebola

Ebola may have existed over 20 million years ago, according to researchers

Most Popular

How Technology Is Changing the Real Estate Industry?

Study Reveals High Turnover in Scientific Research Careers: What This Means for Future Scientists

Nikolay Karpenko Biography, Photo, Career, Accomplishments

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

China’s Tiangong Space Station to Expand Its Capabilities With New Modules

Recommended Stories

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Energy

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

NASA Astronaut Hospitalized After Returning from Extended Space Mission